BTCY: Biotricity Inc. Price-to-Revenue Coefficient

Brandmark of Biotricity Inc (BTCY)

Biotricity, Inc. (BTCY) leverages the growing demand from clinics for remote cardiac monitoring. Cloud-based data transmission minimizes patient transportation costs. The market cap-to-revenue ratio helps avoid purchasing the asset at its peak, while the 0.40 indicator reflects current dynamics. Biotricity, Inc. (BTCY) is implementing Bioflux AI platforms that automatically detect arrhythmia, eliminating the need for physicians to perform manual ECG analysis.

BTCY Biotricity: P/S Multiple in the range 07/04/2022 - 08/10/2024

Biotricity, Inc (BTCY) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart biotricity.com|BTCY - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Biotricity, Inc|BTCY - Enterprise Value
- company book value details:
Accounting Value per Share Biotricity|BTCY - Book Capitalization|Market Capitalization to Book Value biotricity.com|BTCY - Cumulative Company Assets
- debt obligations and liquidity statistics:
Aggregate Debt to Capital Biotricity, Inc.|BTCY - Long-Term Debt to Equity Ratio|Current Liabilities to Capital Biotricity Inc|BTCY - Company Total Debt|Debt to Net Assets Ratio Biotricity, Inc|BTCY - Company Long-Term Debts|Short-Term Debt Volume Biotricity|Immediate Liquidity Ratio biotricity.com
- business earnings and investment ratios data:
BTCY - Net Profit|Future Profit Biotricity, Inc.|BTCY - Price to Earnings Ratio|Market Cap to Projected Earnings Biotricity Inc.|BTCY - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Biotricity, Inc|BTCY - Operating profit before deduction of amortization|Earnings per share for the last four quarters Biotricity|BTCY - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months biotricity.com|BTCY - Net earnings per share growth this year|Expected net earnings per share growth next year Biotricity, Inc.
- issuer revenue and sales details:
BTCY - Company Sales|Company Projected Revenue Volume biotricity.com|BTCY - P/S Multiple|Market Cap to Future Revenue Ratio Biotricity, Inc
Summary company analytics:biotricity.com, BTCY
Brand item of Biotricity

The P/S ratio determines the market value of the business relative to generated revenue, allowing for an assessment of the asset's premium amid the Fed's tight monetary policy. By analyzing changes in the price-to-sales ratio, an investor correlates the price action of Biotricity, Inc. (BTCY) with the scaling of the Bioflux system and the implementation of AI analytics, where a decline in the metric may signal either undervaluation or systemic risks.

Competing companies

HIMS (forhims.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple HNGE (Hinge Health)|Price-to-Revenue Coefficient Teladoc Health (TDOC)|Talkspace Corp - P/S Multiple|LifeMD, Inc. (LFMD) - Market Cap to Revenue|AMWL: P/S Multiple|MGRX - Price-to-Revenue Coefficient|Market Cap to Revenue DRIO|VSEE (VSee) - Market Cap to Sales Volume|Market Cap to Revenue MNDR (MANADR)|ACCD - Price to Sales|Lytus Technologies - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio OTRK|SHL Telemedicine, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Thorne HealthTech Inc THRN